2 Beaten-Down Stocks to Buy and Hold
Equity markets have been volatile throughout the year. We may or may not be out of the woods, but focusing on the short-term performance of stocks is not the best strategy. Regardless of what happens over the next six months, it's still worth it to invest in companies that look likely to perform well in the long run.
It's even better if these stocks can be bought on the dip because they have faced challenges from which they are likely to recover. Here are two great examples to consider: (NASDAQ: MRNA) and Regeneron Pharmaceticals (NASDAQ: REGN).
Image source: Getty Images.
Source Fool.com
Regeneron Pharmaceuticals Inc. Aktie
507,40 €
2,93 %
Die Regeneron Pharmaceuticals Inc. Aktie steht gut da: Deutlich mehr Buy- als Sell-Einschätzungen in der Community.
Mit einem Kursziel von 948 € für Regeneron Pharmaceuticals Inc. könnte der aktuelle Kurs von 507.4 € um mehr als die Hälfte steigen.
